Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia

G Marshall; M Haber; E Kwan; L Zhu; D Ferrara; X Chengyuan; Michael Brisco; Pamela Sykes; Alexander Morley; null Webster; L Dalla Pozza; K Waters; M Norris

Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia

G Marshall, M Haber, E Kwan, L Zhu, D Ferrara, X Chengyuan, Michael Brisco, Pamela Sykes, Alexander Morley, Webster, L Dalla Pozza, K Waters, M Norris

Research output: Contribution to journal › Article › peer-review

47 Citations (Scopus)

Original language	English
Pages (from-to)	704-709
Number of pages	6
Journal	Journal of Clinical Oncology
Volume	21
Issue number	4
Publication status	Published - 2003

Cite this

@article{a44b7976ca9448a3bf6178c00aa9c688,

title = "Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia",

author = "G Marshall and M Haber and E Kwan and L Zhu and D Ferrara and X Chengyuan and Michael Brisco and Pamela Sykes and Alexander Morley and Webster and {Dalla Pozza}, L and K Waters and M Norris",

year = "2003",

language = "English",

volume = "21",

pages = "704--709",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "4",

}

TY - JOUR

T1 - Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia

AU - Marshall, G

AU - Haber, M

AU - Kwan, E

AU - Zhu, L

AU - Ferrara, D

AU - Chengyuan, X

AU - Brisco, Michael

AU - Sykes, Pamela

AU - Morley, Alexander

AU - Webster, null

AU - Dalla Pozza, L

AU - Waters, K

AU - Norris, M

PY - 2003

Y1 - 2003

M3 - Article

SN - 0732-183X

VL - 21

SP - 704

EP - 709

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 4

ER -